Home
About Us
Mission and Values
Leadership
Executive Leadership Team
Board of Directors
Scientific Advisory Board
Science
Pipeline
Therapeutics
Lirafugratinib
Rivoceranib
Camrelizumab
Publications and Presentations
News
Press Releases
Events
Investors
Partnering
Careers
Contact Us
Search
Home
About Us
Mission and Values
Leadership
Executive Leadership Team
Board of Directors
Scientific Advisory Board
Science
Pipeline
Therapeutics
Lirafugratinib
Rivoceranib
Camrelizumab
Publications and Presentations
News
Press Releases
Events
Investors
Partnering
Careers
Contact Us
Search
Search
Home
About Us
Mission and Values
Leadership
Executive Leadership Team
Board of Directors
Scientific Advisory Board
Science
Pipeline
Therapeutics
Lirafugratinib
Rivoceranib
Camrelizumab
Publications and Presentations
News
Press Releases
Events
Investors
Partnering
Careers
Contact Us
ESMO
ESMO
January 29, 2026
0
Start date:
October 23, 2026
End date:
October 27, 2026
Location:
Madrid, Spain
PREV
CCF
NEXT
AHPBA